Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 1 Population characteristics of the GOLDN study and participants without diabetes in the BPRHS 1

From: Genome-wide interaction of genotype by erythrocyte n-3 fatty acids contributes to phenotypic variance of diabetes-related traits

  GOLDN (n = 820)    BPRHS (n = 716)   
  Mean SD Range (Q1-Q3) Mean SD Range (Q1-Q3)
Age, y 48.9 16 39-62 56.0 7.53 50-61
Female, n (%) 414 (50.5)    501 (70.0)   
BMI, kg/m2 28.5 5.5 24.8-31.4 30.6 6.27 26.3-34.0
Energy intake, kJ 8942 5259 5926-10684 10051 5523 6343-11998
Fasting glucose, mmol/L 5.66 1.09 5.11-5.88 5.41 0.61 5.00-5.83
Fasting insulin, pmol/L 97.7 57.4 62.5-111.1 99.7 65.4 57.6-122.2
HOMA-IR 3.61 2.48 2.15-4.2 3.54 2.60 1.92-4.38
Adiponectin, ng/mL 8109 4500 4664-10210 NA NA NA
Erythrocyte n-3 PUFA,% 5.78 1.1 5.00-6.33 6.47 1.37 5.60-7.08
Erythrocyte n-6 PUFA,% 28.2 1.5 27.4-29.2 31.0 2.19 30.1-32.3
Erythrocyte DHA,% 3.01 0.86 2.37-3.46 3.91 1.05 3.23-4.51
Erythrocyte EPA,% 0.52 0.23 0.39-0.59 0.42 0.23 0.29-0.49
Erythrocyte DPA,% 2.11 0.29 1.93-2.27 2.00 0.35 1.79-2.19
Erythrocyte ALA,% 0.14 0.03 0.11-0.16 0.13 0.06 0.09-0.16
Erythrocyte AA,% 13.6 1.1 12.9-14.4 16.5 1.84 15.5-17.6
(n-6)/ (n-3) PUFA 5.06 0.98 4.39-5.74 5.02 1.17 4.30-5.58
AA/ (EPA + DHA) 4.14 1.11 3.36-4.85 4.07 1.13 3.32-4.71
AA/ DHA 4.89 1.41 3.86-5.78 4.51 1.28 3.65-5.24
AA/ EPA 29.6 10.1 22.8-35.9 46.9 19.5 33.6-56.7
  1. 1BMI, body mass index; SD, standard deviation; Q, quartile; HOMA-IR, homeostasis model assessment of insulin resistance; PUFA, polyunsaturated fatty acid; DHA, docosahexaenoic acid; EPA, eicosapentaenoic acid; DPA, docosapentaenoic acid; ALA, alpha-linolenic acid; AA, arachidonic acid.